Hypertension management 2011: optimal combination therapy. - Wikidata - awgldk - TriplyDB

Hypertension management 2011: optimal combination therapy.

Hypertension management 2011: optimal combination therapy.

http://www.wikidata.org/entity/Q34194758

about

Antihypertensive drug treatment changes in the general population: the CoLaus study (-)Doxazosin is a necessary component for the hypotensive effect of (±)doxazosin during long-term administration in conscious rats Effect of initial antihypertensive combination therapy on primary stroke prevention.Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.Leg edema with (S)-amlodipine vs conventional amlodipine given in triple therapy for hypertension: a randomized double blind controlled clinical trial.Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial.Current perspectives on combination therapy in the management of hypertension.Different associations between beta-blockers and other antihypertensive medication combinations with brachial blood pressure and aortic waveform parameters.A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertension.A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.Efficacy and tolerability of telmisartan plus amlodipine in asian patients not adequately controlled on either monotherapy or on low-dose combination therapy.I brazilian position paper on antihypertensive drug combination Should two-drug initial therapy for hypertension be recommended for all patients?The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension.Thiazide-like/calcium channel blocker agents: a major combination for hypertension management.Resistant hypertension: what the cardiologist needs to know.Resistant Hypertension: Mechanisms and Treatment.Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.Src Family Kinases (SFK) Mediate Angiotensin II-Induced Myosin Light Chain Phosphorylation and Hypertension Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness.Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.A geripill for successful aging.Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2).Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial.To what extent do prescribing practices for hypertension in the private sector in Zimbabwe follow the national treatment guidelines? An analysis of insurance medical claims.Antihypertensive monotherapy or combined therapy: which is more effective on functional status?Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.School performance affects adolescent blood pressure.ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.Effect of Onopordon acanthium L. as Add on Antihypertensive Therapy in Patients with Primary Hypertension Taking Losartan: a Pilot Study.Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study.Effect of food on the oral bioavailability of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide fixed dose combination tablets in healthy subjects.

P2860

Q33614990-6631EB94-9429-4C79-9472-1668B9DC44D4 Q33823685-8F10A5A8-3EEB-4995-B7BB-1E125B67C3E3 Q35681069-AD1EBF2A-0A1F-4BBF-9C38-49D0072A187D Q36038635-7DDE4BE3-43C6-424A-97DB-01E94BC44F98 Q36087088-D2F832DB-1239-4C15-A055-3BB6F653BE18 Q36120769-600AEAA7-5BD0-49B4-AB5C-79A2871FB539 Q36796494-9F80BBF8-79B5-4997-92F1-62118E19DDF1 Q36801950-4D195760-7036-4474-B8A6-F097A157D2B8 Q36975801-E9B98D37-D9ED-47DF-9A8C-8CDB38F81719 Q37135698-3962A9FF-67AC-4FDC-849A-CDA2C717ADB6 Q37192911-B8E5BD7E-05B8-4D37-91B6-5FA05ABB9166 Q37203105-E2368A8D-5EBF-40EF-B593-854A4DAA1051 Q37639773-A4660BBE-CFAF-46C6-9444-84D52A01C25A Q37703801-8E23D032-A5EE-4AAA-AB63-A290F6201126 Q38015765-B9C8ABB0-820B-471E-9C97-A61182F5EEC7 Q38182880-CA834913-181C-4311-A75F-D427923AB158 Q38243976-CCC7A003-5EFE-42EB-8D0C-A54AA0CD8EE6 Q38564177-2F4D344F-6D4E-49FD-BB81-43494F8E3BA2 Q38734859-EEA35FDC-03C8-4FD3-8607-211AA4D84D3C Q40987557-51D549B4-8670-4DCC-9D28-F3429DDAFFFD Q41096913-EE3130C3-C8EB-42E6-8BB5-ACCB234F148B Q41990860-0FE995CB-BE91-4D6F-B669-72F7645DD63A Q42644817-80DA9A14-19D0-4332-A762-F427B28B67D4 Q43432036-81EC5F0B-1C8C-4085-82D8-3FF0956BFECE Q44585336-896D2382-7FC4-4C3B-9770-7CB9F9273982 Q46877368-682398C2-7E6B-4767-8999-6E6F59A0A5FC Q47101575-70779815-B033-4AE3-93FA-CB3E9890282B Q48237130-0044D189-7E76-4C4E-AC04-6EA4F61E38F6 Q50016993-08616EAF-E128-4956-8010-63D785C28611 Q50803695-CCB1FC9E-1D35-46A5-A236-56FC0068A0E7 Q51752848-C22055B4-933D-449E-9F69-705EE42ADFD3 Q52578967-5E87AF0F-33A0-45C0-86D5-2168EA66BA4B Q52802931-ACAE108E-B5B6-4116-9AE5-5EE7A01C5982 Q52846002-E85F7847-D59B-4C82-972C-EBB40536F750 Q53774472-11B1EDF9-6277-4A40-89F9-79552D683206

P2860

Hypertension management 2011: optimal combination therapy.

http://www.wikidata.org/entity/Q34194758

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Hypertension management 2011: optimal combination therapy.

@ast

Hypertension management 2011: optimal combination therapy.

@en

Hypertension management 2011: optimal combination therapy.

@nl

type

label

Hypertension management 2011: optimal combination therapy.

@ast

Hypertension management 2011: optimal combination therapy.

@en

Hypertension management 2011: optimal combination therapy.

@nl

prefLabel

Hypertension management 2011: optimal combination therapy.

@ast

Hypertension management 2011: optimal combination therapy.

@en

Hypertension management 2011: optimal combination therapy.

@nl

P1433

Q34194758-16B9ECBA-4D2A-4454-83FE-C05A7FDF9712

P1476

Q34194758-104AD7F8-073C-4BA3-BDC8-A572A72E8A19

P2093

Q34194758-623B07EC-E675-46FB-9954-0CBBC74D0A85

Q34194758-74F7EE40-B376-4B71-9BD6-7B47CE4562BF

P2860

Q34194758-2783957D-AF1C-453C-BF31-7AEEAD5BBA1C

Q34194758-27DAD8BB-A3C1-4AD2-AFD0-73CEF396F627

Q34194758-2854B354-3B93-4E54-85D4-0188DB604240

Q34194758-2D6CD59F-D5E2-4670-AC37-836215F46956

Q34194758-2EE562C7-A2F0-4441-B54F-81562437E650

Q34194758-3149AAF5-C392-461D-876B-B9885A80CAF8

Q34194758-33A76B70-99E8-450F-9E19-90CC7F467AF5

Q34194758-457CBCE9-3E15-441B-A6FA-175406FF60EB

Q34194758-4A7F1B16-0FFD-433C-8403-C07A1A6EECE6

Q34194758-55B446FC-7C81-4333-A14C-98D5EF32E6D2

P304

Q34194758-5BC2BF5E-05D2-4DDB-A4ED-966E4EA3677B

P31

Q34194758-047EDC57-7038-4D32-8F87-795166F6473D

P356

Q34194758-9F3D10B9-51D1-4E9D-A215-AF14DBBD3D48

P433

Q34194758-3AF54C57-ACEC-4EEE-A69E-D42B98FC3AD7

P478

Q34194758-FE2BB73C-62B4-4B15-AF80-79C61F3D5B06

P577

Q34194758-87867865-AD36-4F6D-9EF6-026202797304

P5875

Q34194758-C695E667-4852-4CEF-A5F5-7865859067D1

P698

Q34194758-E592C4B0-F311-4CD0-9C4A-91F60037A011

P356

P1433

European Heart Journal

P1476

Hypertension management 2011: optimal combination therapy.

@en

P2093

Franz H Messerli

http://www.w3.org/2001/XMLSchema#string

Peter S Sever

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Hypertension treatment and control in five European countries, Canada, and the United States.

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

P304

2499-2506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHR177

http://www.w3.org/2001/XMLSchema#string

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51242187

http://www.w3.org/2001/XMLSchema#string

P698

21697169

http://www.w3.org/2001/XMLSchema#string